Amlodipine-induced gingival hyperplasia: A report of two cases.

Authors :: Lakshmi, G. Sri
Tejaswini, G.
Alekhya, B.
Manuel, Maria Bethasaida
Ram, R.
Kumar, V. Siva
Source :: Journal of Clinical & Scientific Research; 2022Supplement, Vol. 11, pS55-S57, 3p
Publication Year :: 2022
Abstract: Drugs associated with gingival overgrowth fall into three broad categories - anticonvulsants, immune suppressants and calcium channel blockers. Amlodipine is a third-generation dihydropyridine. The prevalence of amlodipine-induced gingival hyperplasia is 4.2%. We report two patients with the amlodipine-induced gingival hyperplasia. [ABSTRACT FROM AUTHOR]